Captrust Financial Advisors Buys Shares of 8,109 Aetna Inc. (AET)
Captrust Financial Advisors bought a new position in Aetna Inc. (NYSE:AET) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 8,109 shares of the company’s stock, valued at approximately $1,231,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Norinchukin Bank The grew its holdings in shares of Aetna by 0.7% in the 2nd quarter. Norinchukin Bank The now owns 23,018 shares of the company’s stock worth $3,495,000 after purchasing an additional 164 shares during the last quarter. Origin Asset Management LLP grew its holdings in shares of Aetna by 23.9% in the 2nd quarter. Origin Asset Management LLP now owns 197,233 shares of the company’s stock worth $29,946,000 after purchasing an additional 38,000 shares during the last quarter. Chemical Bank grew its holdings in shares of Aetna by 2.8% in the 2nd quarter. Chemical Bank now owns 48,565 shares of the company’s stock worth $7,374,000 after purchasing an additional 1,315 shares during the last quarter. TIAA CREF Investment Management LLC grew its holdings in shares of Aetna by 6.9% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 1,634,039 shares of the company’s stock worth $248,096,000 after purchasing an additional 106,165 shares during the last quarter. Finally, Roosevelt Investment Group Inc. grew its holdings in shares of Aetna by 8.0% in the 2nd quarter. Roosevelt Investment Group Inc. now owns 1,968 shares of the company’s stock worth $299,000 after purchasing an additional 146 shares during the last quarter. 89.58% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/13/captrust-financial-advisors-buys-shares-of-8109-aetna-inc-aet.html.
Shares of Aetna Inc. (NYSE:AET) traded down 0.21% on Wednesday, hitting $162.49. 598,219 shares of the stock traded hands. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $164.30. The stock has a market cap of $53.96 billion, a PE ratio of 36.07 and a beta of 0.53. The stock has a 50 day moving average of $156.47 and a 200-day moving average of $144.33.
Aetna (NYSE:AET) last released its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.34 by $1.08. The company had revenue of $15.52 billion for the quarter, compared to analysts’ expectations of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same period in the previous year, the business posted $2.21 earnings per share. On average, equities research analysts expect that Aetna Inc. will post $9.55 EPS for the current year.
Several research firms have recently weighed in on AET. Argus reaffirmed a “buy” rating and issued a $185.00 target price (up previously from $165.00) on shares of Aetna in a report on Tuesday. Morgan Stanley upped their target price on shares of Aetna from $172.00 to $179.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $175.00 target price (up previously from $150.00) on shares of Aetna in a report on Wednesday, August 9th. Deutsche Bank AG upped their target price on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $163.00 target price (up previously from $157.00) on shares of Aetna in a report on Friday, August 4th. Seven analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $159.04.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.